The patent covers mathematical algorithms for determining the expression levels of splice isoforms of a gene in a sample using microarrays with exon junction probes. The issued patent is said to fit in Jivan’s broader strategy of providing a complete solution for splice isoform expression, ranging from array design to microarray services to data analysis to PCR validation.
Subha Srinivasan, CEO of JIvan, said: “The issued patent validates company’s position as a leader in the growing market for DNA microarrays to detect alternative splicing. Powerful data analysis is critical to the adoption of splicing arrays, the next generation of expression arrays.”